Page last updated: 2024-08-18

arginine vasopressin and Carcinoma 256, Walker

arginine vasopressin has been researched along with Carcinoma 256, Walker in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Astakhova, TM; Ivanova, LN; Karpova, YD; Khegai, II; Melnikova, VI; Popova, NA; Sharova, NP; Zakharova, LA1
Siddiqui, RA; Williams, JF2

Other Studies

3 other study(ies) available for arginine vasopressin and Carcinoma 256, Walker

ArticleYear
Pattern of MHC class I and immune proteasome expression in Walker 256 tumor during growth and regression in Brattleboro rats with the hereditary defect of arginine-vasopressin synthesis.
    Cellular immunology, 2011, Volume: 271, Issue:2

    Topics: Animals; Antigen Presentation; Antigens, Neoplasm; Arginine Vasopressin; Carcinoma 256, Walker; Chymotrypsin; Cysteine Endopeptidases; Histocompatibility Antigens Class I; Male; Neoplasm Regression, Spontaneous; Neoplasm Transplantation; Proteasome Endopeptidase Complex; Rats; Rats, Brattleboro

2011
Tentative identification of the toxohormones of cancer cachexia: roles of vasopressin, prostaglandin E2 and cachectin-TNF.
    Biochemistry international, 1990, Volume: 20, Issue:4

    Topics: Amino Acids, Branched-Chain; Animals; Arginine Vasopressin; Cachexia; Carcinoma 256, Walker; Dinoprostone; Esterification; Fatty Acids; Ketone Bodies; Male; Muscles; Oxidation-Reduction; Rats; Rats, Inbred Strains; Tumor Necrosis Factor-alpha

1990
The regulation of fatty acid and branched-chain amino acid oxidation in cancer cachectic rats: a proposed role for a cytokine, eicosanoid, and hormone trilogy.
    Biochemical medicine and metabolic biology, 1989, Volume: 42, Issue:1

    Topics: Amino Acids, Branched-Chain; Animals; Arginine Vasopressin; Carcinoma 256, Walker; Dinoprostone; Fatty Acids; Liver; Male; Oxidation-Reduction; Rats; Rats, Inbred Strains; Triglycerides; Tumor Necrosis Factor-alpha

1989